Line 31: | Line 31: | ||
− | <center | + | <center> |
<img src="https://static.igem.org/mediawiki/2017/9/97/T--CPU_CHINA--mainpage_new.png" width = "1300"> | <img src="https://static.igem.org/mediawiki/2017/9/97/T--CPU_CHINA--mainpage_new.png" width = "1300"> | ||
</center> | </center> | ||
− | <center | + | <center> |
<h5>Our HEAD-Treg</h5> | <h5>Our HEAD-Treg</h5> | ||
<video src="https://static.igem.org/mediawiki/2017/1/14/T--CPU_CHINA--mainpagevideo.mp4" controls="controls" class="video" width = "60%"></video> | <video src="https://static.igem.org/mediawiki/2017/1/14/T--CPU_CHINA--mainpagevideo.mp4" controls="controls" class="video" width = "60%"></video> | ||
</center> | </center> | ||
− | <center | + | <center><h3>Description</h3> |
<h4><br>Rheumatoid arthritis (RA) is a serious chronic, inflammatory and systemic autoimmune disease. | <h4><br>Rheumatoid arthritis (RA) is a serious chronic, inflammatory and systemic autoimmune disease. | ||
<br>It is of great essence to develop a novel cell-targeted therapy for RA | <br>It is of great essence to develop a novel cell-targeted therapy for RA |
Revision as of 12:04, 1 November 2017
![](https://static.igem.org/mediawiki/2017/9/97/T--CPU_CHINA--mainpage_new.png)